Want to see KR:002620 full AI Analyst Report?
JEIL PHARMA HOLDINGS INC. (002620) Financial Statements
JEIL PHARMA HOLDINGS INC. Financial Overview
JEIL PHARMA HOLDINGS INC.'s market cap is currently $103.16B. The company's EPS TTM is $549.73; its P/E ratio is 12.22; and it has a dividend yield of 1.04%. JEIL PHARMA HOLDINGS INC. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 657.61B | $ 779.82B | $ 804.04B | $ 792.96B | $ 762.57B |
| Gross Profit | $ 226.27B | $ 206.52B | $ 214.58B | $ 180.48B | $ 180.51B |
| Operating Income | $ 15.07B | $ -11.56B | $ 20.92B | $ -7.55B | $ 1.55B |
| EBITDA | $ 30.02B | $ -38.65B | $ 9.25B | $ -67.00B | $ 6.14B |
| Net Income | $ 14.64B | $ -51.16B | $ -16.25B | $ -83.15B | $ -12.87B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 79.31B | $ 75.88B | $ 59.13B | $ 53.40B | $ 47.22B |
| Total Assets | $ 876.04B | $ 890.43B | $ 880.00B | $ 865.68B | $ 892.42B |
| Total Debt | $ 167.37B | $ 155.21B | $ 214.14B | $ 162.62B | $ 115.07B |
| Net Debt | $ 111.18B | $ 95.39B | $ 177.10B | $ 127.86B | $ 86.49B |
| Total Liabilities | $ 407.55B | $ 453.04B | $ 477.81B | $ 445.88B | $ 392.11B |
| Stockholders' Equity | $ 318.74B | $ 306.95B | $ 319.46B | $ 337.76B | $ 411.73B |
| Cash Flow | |||||
| Free Cash Flow | $ -7.89B | $ -2.32B | $ -14.25B | $ -42.21B | $ -10.33B |
| Operating Cash Flow | $ 390.26M | $ 4.54B | $ -4.42B | $ -20.80B | $ 13.40B |
| Investing Cash Flow | $ -13.44B | $ 2.27B | $ -13.43B | $ -17.56B | $ 7.33B |
| Financing Cash Flow | $ 10.02B | $ 14.22B | $ 20.62B | $ 44.91B | $ -12.24B |
Currency in KRW